Simon M M, Nerz G, Prester M, Moll H
Eur J Immunol. 1985 Aug;15(8):773-83. doi: 10.1002/eji.1830150807.
In this study we report that cloned Thy-1+, L3T4-, Lyt-1-, Lyt-2+, H-Y-specific and H-2Db-restricted cytotoxic T cell lines (CTLL) when induced by lectin or antigen secrete a soluble mediator(s) (SF) that inhibits proliferation and generation of cytotoxic lymphocytes (CTL) in mixed lymphocyte cultures (MLC). The biological activity was separable by gel filtration and appeared as a broad peak in the molecular mass range between 10 000 and 50 000 kDa. It was found that the suppressive activity released by CTLL neither strictly correlates with their cytotoxic potential nor with their ability to produce immune interferon or lymphotoxin. SF was shown to elicit its activity in an antigen-nonspecific manner in that it suppressed the maturation of T lymphocytes responding to both, the appropriate H-Y antigen as well as to unrelated H-2d alloantigens or to the hapten 2,4,6-trinitrophenyl (TNP). The effect of SF on CTL responses was most pronounced in early phases of primary or secondary MLC. When analyzed for its inhibitory activity on precursor cells in populations selected for either Lyt-2- or L3T4- lymphocytes, it was found that SF interfered with the maturation of both subsets. The inhibition of CTL responses elicited by SF could not be reversed by the addition of exogenous interleukin 2. The finding that SF also inhibited the proliferation of some but not all antigen-dependent cloned T cells with helper or cytotoxic potential provides evidence that the factor also may regulate effector lymphocytes. In addition, the results support the assumption that SF exerts its effect directly on the responder rather than the stimulator population, and demonstrate that the development of CTL from their precursor cells is controlled at least in part by the cytotoxic effector cells themselves via a soluble factor(s) that interferes with distinct stages of T cell maturation. These findings again emphasize the expression of multiple functions by CTL and indicate their possible role during the course of an immune response by their capability to eliminate target cells and to secrete a soluble product(s) that mediates feedback control.
在本研究中,我们报告称,克隆的Thy-1⁺、L3T4⁻、Lyt-1⁻、Lyt-2⁺、H-Y特异性且受H-2Db限制的细胞毒性T细胞系(CTLL)在受到凝集素或抗原诱导时,会分泌一种可溶性介质(SF),该介质可抑制混合淋巴细胞培养物(MLC)中细胞毒性淋巴细胞(CTL)的增殖和生成。其生物活性可通过凝胶过滤分离,在分子量范围为10000至50000 kDa之间呈现为一个宽峰。研究发现,CTLL释放的抑制活性既不与它们的细胞毒性潜力严格相关,也不与它们产生免疫干扰素或淋巴毒素的能力相关。SF被证明以抗原非特异性方式发挥其活性,因为它抑制了对合适的H-Y抗原以及无关的H-2d同种异体抗原或半抗原2,4,6-三硝基苯(TNP)作出反应的T淋巴细胞的成熟。SF对CTL反应的影响在初次或二次MLC的早期阶段最为明显。当分析其对选择Lyt-2⁻或L3T4⁻淋巴细胞群体中的前体细胞的抑制活性时,发现SF干扰了这两个亚群的成熟。添加外源性白细胞介素2无法逆转SF引起的CTL反应抑制。SF还抑制了一些但不是所有具有辅助或细胞毒性潜力的抗原依赖性克隆T细胞的增殖,这一发现证明该因子也可能调节效应淋巴细胞。此外,结果支持了SF直接作用于反应细胞而非刺激细胞群体的假设,并表明CTL从前体细胞的发育至少部分受细胞毒性效应细胞自身通过一种干扰T细胞成熟不同阶段的可溶性因子控制。这些发现再次强调了CTL多种功能的表达,并表明它们在免疫反应过程中通过消除靶细胞和分泌介导反馈控制的可溶性产物的能力可能发挥的作用。